Furthermore, a report showed that numerous components of the PI3K/AKT pathway were found to be more frequently targeted in the processes of amplification, mutation, and translocation in cancer patients with abundant activation of the pathway, indicating the potential to exploit the PI3K/AKT pathway for cancer drug discovery [118]. This evidence concerns the gene PIK3CD and cancer.